KR890001698B1 - Stabilization method of pigment of lithospermi radix - Google Patents
Stabilization method of pigment of lithospermi radix Download PDFInfo
- Publication number
- KR890001698B1 KR890001698B1 KR1019860009568A KR860009568A KR890001698B1 KR 890001698 B1 KR890001698 B1 KR 890001698B1 KR 1019860009568 A KR1019860009568 A KR 1019860009568A KR 860009568 A KR860009568 A KR 860009568A KR 890001698 B1 KR890001698 B1 KR 890001698B1
- Authority
- KR
- South Korea
- Prior art keywords
- pigment
- root
- stabilization method
- citric acid
- peg
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
첨부된 도면은 본 발명의 각 실시예에서 제조한 크림제를 측색색차계로 측정한 색차를 나타낸 것이다.The accompanying drawings show the color difference measured by the colorimetric colorimeter of the cream agent prepared in each embodiment of the present invention.
본 발명은 화장품 및 의약품의 원료로 사용할 수 있는 자근 색소의 안정화 방법에 관한 것이다.The present invention relates to a method for stabilizing autologous pigments that can be used as raw materials for cosmetics and pharmaceuticals.
자근은 지치과(Borraginaceae)에 속하는 자초(Lithospermum erythrorhizon Siebold et. Zuccarini (Lithospermum officinale Linn'e var. erythrorhizon Maximowicz))의 뿌리로 이러한 자근의 유기용매 추출액에는 시코닌(Shikonin) 및 그 유도체인 다음과 같은 구조식으로 표현되는 색소 성분이 함유되어 있다.Root is the root of Lithospermum erythrorhizon Siebold et.Zuccarini (Lithospermum officinale Linn'e var.erythrorhizon Maximowicz) belonging to Borraginaceae. The pigment component represented by the same structural formula is contained.
이와 같은 성분은 한방에서 이미 소염, 해열 및 해독의 목적으로 여러 제제에 배합되어 사용되고 있음은 물론, 살균 및 항염증 작용이 있어 종창, 화상, 동상, 습진, 수포 및 치질등에 연고로 외용되고 있는 것일뿐만 아니라(대한 약전 해설 3판, 제736면 내지 제747면)최근 일본에서는 화장품의 원료로도 사용되고 있는 것이다.Such ingredients are already used in various preparations for the purpose of anti-inflammatory, antipyretic and detoxification in oriental medicine, as well as having bactericidal and anti-inflammatory effects and are used externally as ointments for swelling, burns, frostbite, eczema, blisters and hemorrhoids. In addition, it is being used as a raw material of cosmetics in Japan recently (Third Edition, page 736 to page 747).
자근의색소 성분은 적색(pH6.1부근), 보라색(pH8.8부근) 및 청색(pH10부근)을 나타내는데 이는 색소성분이 일광 및 열등에 의하여 색이 변하는 관계로 화장품으로 사용할 경우에는 색소 성분을 안정화 시켜야만 하는 문제점이 있다.The pigment components of the root roots represent red (near pH 6.1), purple (near pH 8.8), and blue (near pH 10), which are used in cosmetics because the color of the pigment changes due to sunlight and inferiority. There is a problem that must be stabilized.
이러한 문제점을 해결하기 위하여 일본에서는 감마오리자놀을 사용(일본특허 출원 제 80-55108호)하고 있으나, 연구 결과 본 발명자등은 구연산을 사용하므로써 감마오리자놀 보다는 구입이 용이할뿐만 아니라 가격이 저렴하고 처리후 안정 효과 또한 우수한 본 발명을 완성하게 되었다.In order to solve this problem, in Japan, gamma-oryzanol is used (Japanese Patent Application No. 80-55108), but the study results show that the present inventors use citric acid, which is not only easier to purchase than gamma-oryzanol, but also cheaper and after treatment. The stabilizing effect is also completed the excellent invention.
즉, 본 발명에서는 수용성 크림 기제에 자근 추출액을 0.05M-0.5M의 구연산 완충용액(pH3-6)과 함께 첨가하므로써 pH변화에 의한 색변화 및 시코닌계 색소와 구연산의 상호 작용에 의한 색변화를 동시에 억제할 수 있었으며, 본 발명에 따라 자근 색소를 함유한 크림제제를 제조할 경우, 제조 원가의 절감 효과 및 색소의 안정성을 보다 현저하게 향상시킬 수 있었다.That is, in the present invention, by adding the root extract extract with 0.05M-0.5M citric acid buffer solution (pH3-6) to the water-soluble cream base, the color change by the pH change and the color change by the interaction of the ciconin pigment and citric acid At the same time, it was possible to suppress it, and when producing a cream formulation containing autologous pigments according to the present invention, it was possible to more significantly improve the effect of reducing production costs and stability of the pigments.
본 발명에서 사용한 자근 추출액은 자근 절편 100g을 유기용매(에테르, 벤젠, 클로로포름, 에탄올등)500ml로 24시간동안 3회 추출한 후, 농출 증발기로 유기 용매를 완전 제거하여 올리브유 100ml에 재용해 시킨 것이다.The root extract of the root extract used in the present invention was extracted three times for 24 hours with 500 ml of an organic solvent (ether, benzene, chloroform, ethanol, etc.) three times for 24 hours, and then completely dissolved in a concentrated evaporator and redissolved in 100 ml of olive oil.
[실시예 1]Example 1
다음에 기재한 성분과 함량에 따라 크림 제제를 제조하였다.A cream formulation was prepared according to the ingredients and contents described below.
폴리에틸렌 글리콜 400과 폴리에틸렌 글리콜 4000을 수욕상에서 용해하여 교반하면서 혼화시킨 다음, 약 75℃로 유지 시켰다. 여기에 라우릴 황산나트륨과 자근추출액을 각 완충액 또는 정제수에 용해시켜 75℃로 미리 가온시킨 액을 가한 다음, 고화될때까지 잘 교반화면서 혼화하여 자근 추출액을 함유한 크림제제를 제조하였다. 이때 크림제제1도의 1-A,1-B, 및 1-C는 모두 0.1N HC1용액 및 0.1N NaOH 용액을 사용하여 pH6으로 조정하였다.Polyethylene glycol 400 and polyethylene glycol 4000 were dissolved in a water bath, mixed with stirring, and maintained at about 75 ° C. Sodium lauryl sulfate and the root extract were dissolved in each buffer or purified water, and the solution was pre-warmed to 75 ° C., and then mixed with stirring until it solidified, thereby preparing a cream formulation containing the root extract. At this time, 1-A, 1-B, and 1-C of the
제조된 크림제제를 공기와 일광에 노출시켜 일정시간 경과후에 측색색차계(Model TC-1500MC, Tokyo Denskoku Co.Ltd.제조)를 사용하여 색차(△E)를 측정하였다(제 1 도 참조).The prepared cream formulation was exposed to air and sunlight, and after a certain time, color difference (ΔE) was measured using a colorimeter (Model TC-1500MC, manufactured by Tokyo Denskoku Co. Ltd.) (see FIG. 1).
[실시예 2]Example 2
다음에 기재한 성분과 함량에 따라 크림 제제를 제조하였다.A cream formulation was prepared according to the ingredients and contents described below.
백색 바셀린 및 스테아릴 알코올을 수욕상에서 용해하여 교반하면서 혼화시킨 다음, 약75℃로 유지시켰다. 여기에 프로필렌 글리콜, 라우릴 황산나트륨, 파라안식향산에틸 및 자근 추출액을 완충액 또는 정제수에 용해시켜 75℃로 미리 가온한 액을 가한다음, 고화될때까지 잘 교반하면서 혼화하여 자근 추출액을 함유한 크림제제를 제조하였다.White petrolatum and stearyl alcohol were dissolved in the water bath, mixed with stirring and then maintained at about 75 ° C. To this, propylene glycol, sodium lauryl sulfate, ethyl parabenzoate, and root extract were dissolved in buffer or purified water, and the solution warmed up to 75 ° C. was added to the mixture, and then mixed with stirring until it solidified to prepare a cream formulation containing the root extract. It was.
이때 크림제제2도의 2-A와 2-B모두 0.1N HC1용액 및 0.1N NaOH용액을 사용하여 pH6으로 조정하였다. 제조된 크림제제는 실시예 1에서와 같은 방법으로 색차를 측정하였다(제 2 도 참조).At this time, both 2-A and 2-B of cream preparation 2 were adjusted to pH 6 using 0.1N HC1 solution and 0.1N NaOH solution. The prepared cream formulations measured the color difference in the same manner as in Example 1 (see FIG. 2).
[실시예 3]Example 3
0.5M의 구연산 완충용액을 사용하여 pH를 3으로 조정한 것이외에는 실시예 2와 동일한 조성 및 방법으로 크림 제제를 제조하고 색차를 측정하였다(제 3 도 참조).A cream formulation was prepared in the same composition and method as in Example 2 except that the pH was adjusted to 3 using 0.5M citric acid buffer solution, and the color difference was measured (see FIG. 3).
이때 크림제제 3도의 3-A는 0.5M구연산 완충용액 (pH3)At this time, 3-A in cream formulation 3 is 0.5M citric acid buffer solution (pH3).
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019860009568A KR890001698B1 (en) | 1986-11-12 | 1986-11-12 | Stabilization method of pigment of lithospermi radix |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019860009568A KR890001698B1 (en) | 1986-11-12 | 1986-11-12 | Stabilization method of pigment of lithospermi radix |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880005923A KR880005923A (en) | 1988-07-21 |
KR890001698B1 true KR890001698B1 (en) | 1989-05-18 |
Family
ID=19253344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019860009568A KR890001698B1 (en) | 1986-11-12 | 1986-11-12 | Stabilization method of pigment of lithospermi radix |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR890001698B1 (en) |
-
1986
- 1986-11-12 KR KR1019860009568A patent/KR890001698B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR880005923A (en) | 1988-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4895839A (en) | Pharmaceutical and cosmetic compositions containing complexes of flavanolignans with phospholipids | |
US4052513A (en) | Stable topical anesthetic compositions | |
JP4780429B2 (en) | Minoxidil-containing preparation | |
US5225189A (en) | Minoxidil gel | |
KR100413143B1 (en) | Nimesulide gel systems for topical use | |
RU2138266C1 (en) | Piroxicam-containing anti-inflammatory compositions for topical use, method of solubilization of piroxicam | |
JPH03258711A (en) | Skin-whitening agent for external use | |
KR890001698B1 (en) | Stabilization method of pigment of lithospermi radix | |
WO2020004194A1 (en) | External-use composition | |
JPH11246513A (en) | Aqueous liquid agent of azulene | |
US4961922A (en) | Complexes based on anthralin and a sterol, a process for obtaining them and their use in therapeutics and cosmetics | |
JPH05331066A (en) | Composition for treatment of acne vulgaris | |
FI96742B (en) | Single-phase gel composition containing minoxidil and process for producing it | |
JPS63183518A (en) | Composition for hair | |
WO2020004193A1 (en) | External-use composition | |
ATE1442T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ALL-E- OR 13-Z-7,8-DEHYDRO-RETINOIC ACID AND PROCESS FOR ITS PREPARATION. | |
US3238102A (en) | Solubilization of hydrocortisone acetate | |
JPH0632710A (en) | Skin external preparation | |
IE57562B1 (en) | Compositions and method for stabilization of anthralin | |
EP0435180B1 (en) | Composition for treating hair | |
JP3643167B2 (en) | Topical skin preparation | |
JPS60120806A (en) | Pigment stabilizer | |
DE2708419B2 (en) | Use of 1,2-butanediol methyl ether as a solvent for pharmaceutical injection solutions | |
JPS6058909A (en) | Composition containing shikonin and/or its derivative | |
JP2909759B2 (en) | Transparent cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19951207 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |